Loading company…
Therini Bio, Inc., a California biotech, develops fibrin-targeted therapies for neurological and inflammatory diseases.
Founded in 2016 and based in California, US, Therini Bio, Inc., formerly MedaRed, Inc., was founded by Katerina Akassoglou and is led by CEO Tara Nickerson. Its lead programs target Alzheimer's disease and diabetic eye disease. In April 2023, it raised USD 36 million in Series A funding co-led by MRL Ventures Fund, Sanofi Ventures, SV Health Investors and The Alzheimer's Drug Discovery Foundation. In May 2025, it raised USD 39 million in Series A funding led by new investor Angelini Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in